Medtronic, Inc. (NYSE:MDT) is a Minneapolis-based medical technology company. Medtronic, Inc. (NYSE:MDT) declared that it is going to host an institutional investor and analyst meeting on June 5, 2014 in New York City at 8:30 am. The prime target of the meeting is to highlight the company’s strategy for executing the growth in the market leadership role. The management team of the company will be highlighting all these things to establish a reliable performance, deliver consistently and at the same time create a long term shareholder value. Medtronic, Inc. (NYSE:MDT) net profit margin is 21.20% and weekly performance is 3.29%. On last trading day company shares ended up $60.99. Analysts mean target price for the company is $65.44. Medtronic, Inc. (NYSE:MDT) distance from 50-day simple moving average (SMA50) is 2.62%.
Boston Scientific Corporation (NYSE:BSX) is banding together with Braintree, Cambridge, Quincy, and Somerville to jointly promote the region’s life sciences industry, a dramatic shift from the strategy of Thomas M. Menino, who as mayor worked to lure biotechs and other cutting-edge companies from neighboring cities. Boston Scientific Corporation (NYSE:BSX) shares advanced 1.57% in last trading session and ended the day on $12.93. BSX gross Margin is 69.60% and its return on assets is -0.70%.Boston Scientific Corporation (NYSE:BSX) quarterly performance is 0.15%.
CONMED Corporation (NASDAQ:CNMD) a medical technology company specializing in medical devices for orthopedic and general surgery, announced that the Company will participate in the 2014 Bank ofAmerica Merrill Lynch Health Care Conference on Tuesday, May 13, 2014at 11:20 AM Pacific Time. The event will be held in Las Vegas at theEncore at Wynn Hotel. CONMED Corporation (NASDAQ:CNMD) shares moved up 3.18% in last trading session and was closed at $49.62, while trading in range of $47.36 – $49.93. CONMED Corporation (NASDAQ:CNMD) year to date (YTD) performance is 17.28%.
Bacterin International Holdings, Inc. (NYSEMKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, on 6 may reported financial results for the first quarter ended March 31, 2014. The Company reported quarterly revenues just over $8.9 million, and a net loss for the quarter of approximately $4.1 million, or ($0.08) per common share. Bacterin International Holdings Inc. (NYSEMKT:BONE) ended the last trading day at $0.680. Company weekly volatility is calculated as 6.11% and price to cash ratio as 12.42.Bacterin International Holdings Inc. (NYSEMKT:BONE) showed a negative weekly performance of -8.11%.
Smith & Nephew plc (NYSE:SNN)‘s stock had its “hold” rating reaffirmed by investment analysts at Numis Securities Ltd in a note issued to investors on Tuesday, American Banking News reports. They currently have a GBX 1,000 ($16.84) target price on the stock. Numis Securities Ltd’s price objective indicates a potential upside of 7.93% from the company’s current price. Smith & Nephew plc (ADR) (NYSE:SNN) shares advanced 1.53% in last trading session and ended the day on $78.35. SNN gross Margin is 74.80% and its return on assets is 9.90%.Smith & Nephew plc (ADR) (NYSE:SNN) quarterly performance is 4.79%.